Axxam
VC Fund
Milan, Italy
Axxam is a VC fund in Milan focused on SaaS and Finance. Axxam is focused on the development of small molecule drugs with the ability to target inflammation directly. The company was founded in 2011 and is based in Milan, Lombardia.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Axxam invests in
Stages Axxam invests in
Countries Axxam invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Investment Focus
Industry
- SaaS 1 (50%)
- Finance 1 (50%)
- Software 1 (50%)
- Accounting 1 (50%)
- Health Care 1 (50%)
Stage
- Pre-Seed 1 (50%)
- Series A 1 (50%)
Country
- Germany 1 (50%)
- Morocco 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alessandro Sidoli
Co-Founder and CEO
|
Co-Founder and CEO | Total investments: 0 | Find email | |
|
Stefan Lohmer
Co-Founder, Chairman and CEO
|
Co-Founder, Chairman and CEO | Total investments: 0 | Find email | |
|
Luigi Gavazzeni
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
KONTA
|
KONTA is the end-to-end vendor spend management platform. They offer finance, accounting, software, artificial intelligence, purchasing, corporate finance, audit, reconciliation, collaboration, communication, accounting export, payment management, and reporting. | $223.6K / Pre-Seed / Jul 06, 2021 | |
Acousia Therapeutics
|
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug candidates for the treatment of hearing loss.Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells bycellular regeneration originating from supporting cells.ASpherecousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, these therapies will have the potential to treat the age-related decrease in hearing capacity. | $2.7M / Series A / Dec 14, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Axxam invest in?
Axxam invests primarily in SaaS, Finance and Software startups, most often at Pre-Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Axxam?
Public channels for Axxam include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Axxam?
The team at Axxam includes Alessandro Sidoli (Co-Founder and CEO), Stefan Lohmer (Co-Founder, Chairman and CEO) and Luigi Gavazzeni (Chief Financial Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
